Skip to content

Clinical observational study of the CE-marked uCentum

Clinical observational study of the CE-marked uCentum

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024661
Enrollment
135
Registered
2021-03-03
Start date
2021-05-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M40-M54

Interventions

Group 1: non-interventional study: retrospective evaluation arm 1, no intervention

Sponsors

ulrich GmbH & Co. KG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The patient is at least 18 years old; 2. The patient has undergone surgery with uCentum at least one year and at most five years ago; 3. The patient is capable of understanding the nature, significance, and implications of their decision to participate in the clinical observational study and can act accordingly; 4. A consent form, personally dated and signed by the patient, is available.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
The primary endpoint is postoperative improvement in the Core Outcome Measures Index (COMI). It is collected via questionnaires and recorded once retrospectively.

Secondary

MeasureTime frame
- postoperative COMI back - postoperative back pain and leg pain on a numeric pain rating scale (NPRS; numeric pain rating scale) - fusion status at last routine check-up (Lenke classification) - Infra- and postoperative complications (especially implant- and procedure-related complications)

Countries

Germany

Contacts

Public ContactMarcus Richter

St. Josefs Hospital

mrichter@joho.de0611 177-3701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026